Genome doubling in mature gut cells may repair surface defects and extend remaining life
In old mice, briefly inducing genome doubling and enlargement in mature absorptive gut cells could extend remaining life while baseline gut renewal continues. The claim fails if benefit requires extra production of new cells or persists when genome doubling is selectively blocked
Stage of verification
- Hypothesis published2026-10-06
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Specialised cell of an organ
Mature absorptive epithelial cells
Mature epithelial cells that carry out absorption
Where this hypothesis actsAt the edges of intestinal microinjuries in old mice
Hypotheses on this target 1
Function restoration
Reprogramming
Transplantation
Elimination
Proliferation
What is proposed
Briefly enhance endoreduplication to enlarge cells and compensate for lost surface
With whatGene delivery
HowTargeted, transient cyclin E1 expression with reversible restriction of mitotic entry exclusively in mature cells, while preserving baseline intestinal renewal
Possible result
Possible restoration of epithelial coverage, shorter-lived microdefects and increased remaining lifespan
From the recordМинимальный набор мишеней миметика кишечного восстановления состоит из одной популяции: зрелых всасывающих эпителиальных клеток по краям микроповреждений.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Small wounds in the gut lining might be repaired by making surviving cells cover more ground. The unexpected move is to enlarge mature absorption cells by doubling their genetic material without dividing them, while leaving ordinary cell replacement intact. This is a proposal generated by the pipeline, not a measured repair or lifespan result.
- Brief, targeted production of cyclin E1, a protein that regulates copying of genetic material, together with a reversible block on entry into cell division, is proposed to induce genome doubling in mature absorption cells.
- Genome doubling is proposed to enlarge those existing cells while they remain mature absorption cells rather than become sources of new replacement cells.
- Their added apical surface, the side facing the gut contents, is proposed to cover at least as much area as the missing lining.
- Coverage is proposed to restore function and shorten the time that small wounds remain open.
- Shorter-lived wounds are proposed to reduce repeated damage.
- Reduced repeated damage is proposed to extend old mice’s remaining lives.
A gap in a tiled floor could be covered by widening the tiles around it instead of adding new tiles. The proposed repair similarly asks existing cells to occupy the missing space.
Where the picture breaks: Gut cells must absorb nutrients, maintain a working barrier and remain healthy. Enough added area does not establish that cells reach the wound, seal it or perform those functions.
- Master questionstep 01 of 04
Useful natural body processes might be reproduced through substances, combinations or other interventions to extend life.
Rests on: The supplied goal is to generate new hypotheses about interventions that reproduce beneficial body processes and explain how they might extend life.
Stated in the chain - Goal pillarstep 02 of 04
The intended output is a defined set of new interventions that imitate natural body processes to extend life.
Rests on: The master question explicitly requests new candidate interventions and their proposed routes to longer life.
Stated in the chain - Gap questionstep 03 of 04
A candidate intervention should have an identifiable set of necessary tissue and cell targets: removing any target from its action should eliminate the lifespan benefit.
Rests on: The preceding goal calls for candidate interventions, but does not require every candidate to be organized around a set of individually indispensable targets.
AssumptionThe chain adopts loss of benefit after excluding each target as the criterion for identifying the necessary target set.
- Hypothesisstep 04 of 04
Mature absorption cells bordering small gut wounds are proposed as the only population that needs additional stimulation. Briefly inducing endoreduplication, copying the genome without dividing the cell, would enlarge them enough to replace missing surface, shorten wounds’ persistence and extend old mice’s remaining lives.
Rests on: The preceding question supplies the requirement to identify necessary targets. The endpoint supplies a proposed answer through surface compensation and predicts that selectively preventing genome doubling in mature cells would remove the benefit.
AssumptionThe proposal assumes that enlarged mature cells can provide functional replacement surface while retaining their identity, and that ordinary cell replacement is sufficient without extra stimulation of replacement-cell production, immune protection or the material supporting the tissue. These are stated premises of the proposed mechanism, not established findings.
What is carried, and what is not. None of the screened sources establishes a link of the proposed intervention-to-lifespan sequence in old mice. Two address the cell-state premise directly but in fruit flies: S2, Nature Communications (2017), found that fully mature absorption cells generally did not resume genome-copying cycles even under repair signals, while S3, a bioRxiv preprint (2026), reported recruitment of absorption cells into a replacement-cell role through reduced genome copy number after injury; neither establishes forced enlargement with mature identity retained, functional wound closure or longer life.S2S3
Where the reasoning is carried by something unstated · 2
- Gap question. The chain adopts loss of benefit after excluding each target as the criterion for identifying the necessary target set.
- Hypothesis. The proposal assumes that enlarged mature cells can provide functional replacement surface while retaining their identity, and that ordinary cell replacement is sufficient without extra stimulation of replacement-cell production, immune protection or the material supporting the tissue. These are stated premises of the proposed mechanism, not established findings.
How a result here could mislead · 3
- A larger gut-facing surface could be counted as successful repair even if the added area does not close the wound or restore absorption and barrier function. What closes it: Actual wound coverage, duration of wound opening, absorption and barrier function must be measured alongside added cell surface. The proposed area requirement is a geometric lower bound, not an established threshold for functional repair.
- Improvement could be credited to enlargement of mature cells when the intervention instead increases replacement-cell production or causes treated cells to acquire a replacement-cell role. What closes it: Cell origin, retained mature identity, genome copy number and cell divisions must be tracked together. Extra replacement-cell production must remain at baseline while ordinary renewal continues; any accompanying increase in immune protection or changes to tissue support must also be distinguished from the claimed surface-repair route.
- Loss of benefit after blocking genome doubling could be interpreted as proof that enlargement is necessary even if the block independently damages cells or disrupts ordinary renewal. What closes it: The blocking condition requires checks of mature-cell survival, function and ordinary renewal, alongside confirmation that genome doubling was actually prevented. The proposed restoration of genome doubling must also restore the claimed repair and lifespan effects.
What would make this wrong. The central sufficiency claim would fail if verified genome doubling enlarged the intended mature cells, preserved their identity and ordinary gut renewal, and supplied the proposed wound coverage, yet failed to restore function or extend remaining life. A benefit that required extra replacement-cell production would contradict the distinguishing prediction; a benefit that persisted despite selective, verified prevention of mature-cell genome doubling would contradict its claimed necessity.
What it would change. If the prediction held, the master question would gain a candidate intervention that reproduces repair by enlarging existing mature cells, with benefit possible without extra replacement-cell production. Work on that candidate would need to establish functional surface coverage and the necessity of the mature-cell response, rather than use added cell production as the measure of repair. Even a positive result in old mice would leave human lifespan benefit and safe treatment conditions unestablished; the supplied material also does not define SPV_2, the outcome label used in the chain, well enough to equate it with a specified lifespan measure.
Sources read · 8
Amitosis of Polyploid Cells Regenerates Functional Stem Cells in the Drosophila Intestine. · Cell stem cell · 2017
“Here, we show that after severe depletion, intestinal stem cells (ISCs) in the Drosophila midgut are replaced by spindle-independent ploidy reduction of cells in the enterocyte-lineage through a process known as amitosis.”
Does not settle: Источник не устанавливает, что усиление эндоредупликации зрелых всасывающих клеток закрывает поверхностные микродефекты, восстанавливает функцию кишечника или продлевает оставшуюся жизнь старых мышей. Он описывает обратный процесс у дрозофилы: снижение плоидности клеток энтероцитарной линии для восстановления популяции кишечных стволовых клеток.
EGFR-dependent TOR-independent endocycles support Drosophila gut epithelial regeneration. · Nature communications · 2017
“These results indicate that fully mature ECs do not generally re-enter the endocycle, even in response to stress-induced signalling that drives regeneration.”
Does not settle: Открытыми остаются возможность искусственно вызвать эндоредупликацию именно в зрелых всасывающих клетках, эффективность экспрессии циклина E1, геометрический порог покрытия дефекта, восстановление функции кишечника и продление оставшейся жизни старых мышей. Исследование проведено на дрозофилах; эндоредупликация наблюдалась преимущественно в энтеробластах и молодых энтероцитах.
Evidence that injury can cause Drosophila gut differentiated, polyploid enterocytes to be recruited as stem cells via paligenosis. · bioRxiv : the preprint server for biology · 2026
“Similarly, the EC recruitment occurs by ploidy reduction and involves genes and checkpoints in paligenosis, but it is not clear how EEs or EBs become ISCs.”
Does not settle: Источник не устанавливает, что усиление эндоредупликации зрелых энтероцитов закрывает микроповреждения, восстанавливает функцию кишечника или продлевает оставшуюся жизнь старых мышей. Исследование проведено на дрозофилах после повреждения эпителия и уничтожения делящихся клеток; адресная экспрессия циклина E1, геометрический порог покрытия и сохранение обычного обновления кишечника не проверялись.
Dynamic Formation of Microvillus Inclusions During Enterocyte Differentiation in Munc18-2-Deficient Intestinal Organoids. · Cellular and molecular gastroenterology and hepatology · 2018
“In contrast, mature MVIs might have a cytoprotective role; the clearance of basolateral microvilli by invagination and fusion with the apical membrane may testify to a previously unrecognized plasticity in enterocyte membrane biology.”
Does not settle: Открытыми остаются эндоредупликация зрелых энтероцитов, увеличение их апикальной площади, закрытие микроповреждений, необходимый охват ткани, сохранение функции кишечника и влияние такого воздействия на продолжительность жизни старых мышей.
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention. · Proceedings of the National Academy of Sciences of the United States of America · 2014
“Tetraploidy constitutes a genomically metastable state that can lead to aneuploidy and genomic instability. Tetraploid cells are frequently found in preneoplastic lesions, including intestinal cancers arising due to the inactivation of the tumor suppressor adenomatous polyposis coli (APC).”
Does not settle: Открытыми остаются последствия кратковременного адресного усиления эндоредупликации в зрелых всасывающих клетках у краёв микроповреждений, восстановление площади и функции эпителия, сохранение обычного обновления кишечника, безопасность циклина E1 и влияние такого воздействия на оставшуюся продолжительность жизни старых мышей или SPV_2.
Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation. · Cancer research · 2012
“Enforced nuclear localization of MEK1 in epithelial cells or fibroblasts was sufficient for hyperactivation of ERK1/2, thereby driving cell proliferation, chromosomal polyploidy, and tumorigenesis.”
Does not settle: Источник не исследует зрелые всасывающие клетки по краям микроповреждений, кратковременную экспрессию циклина E1, восстановление эпителиальной поверхности, сохранение функции кишечника или продолжительность жизни старых мышей. Он также не устанавливает безопасную дозу, длительность или необходимый охват воздействия.
Thymosin beta-4 knockdown in IEC-6 normal intestinal epithelial cells induces DNA re-replication via downregulating Emi1. · Journal of cellular physiology · 2014
“For this purpose, we examined the consequences of shRNA-mediated knockdown of Tβ4 in IEC-6 normal rat small intestinal cells and found that inhibiting Tβ4 expression significantly suppressed their growth and induced apoptosis in some cells.”
Does not settle: Источник не проверяет зрелые всасывающие клетки по краям микроповреждений, экспрессию циклина E1, восстановление площади или функции эпителия и продолжительность жизни старых мышей. Описан другой способ запуска повторной репликации ДНК в культуре клеток тонкого кишечника крысы.
“However, it is important for prevention of genomic instability within this epithelial cell population.”
Does not settle: Источник не устанавливает, что полиплоидия зрелых всасывающих клеток компенсирует утрату эпителиальной поверхности, восстанавливает функцию кишечника или продлевает оставшуюся жизнь старых мышей. Он рассматривает дефицит 53BP1 после гамма-облучения и не проверяет адресную экспрессию циклина E1, обратимое ограничение митоза, площадь покрытия дефекта или сохранение обычного обновления кишечника.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
Which tissues and cells must treatments mimicking bodily processes affect to extend life, and which treatments achieve this?
Original wording · exactly as the pipeline generated it
Какие ткани и клеточные популяции составляют причинно необходимый набор мишеней новых миметиков, какие физиологические процессы и вещества или воздействия ему соответствуют, если исключение каждой мишени устраняет продление жизни?
What this question is asking
The question concerns treatments that copy useful effects of the body's own processes and whether their effects on particular tissues and groups of cells are indispensable for extending life. It asks which processes must be copied, which substances or other interventions can copy them, and which tissues and cells must respond. The proposed test of necessity is that removing each target's contribution, one at a time, eliminates the treatment's life-extending effect. Success means longer remaining life than a comparison group under comparable starting conditions. The removal condition defines the evidence being sought; it is not presented as an experiment that has already succeeded.
- Mimetic
- A substance or intervention intended to reproduce an effect of another signal or bodily process. Reproducing one effect does not establish that it reproduces all effects, including any effect on lifespan.
- Tissue, cell population and target
- A tissue is an organized part of the body composed of cells; a cell population is a group of cells identified by shared features. Here, a target means a tissue or cell population whose response contributes to a treatment's effect.
- Necessary and sufficient
- A contribution is necessary when the benefit disappears without it under the tested conditions. A set is sufficient when producing its effects is enough to obtain the benefit; these are different claims.
- Remaining life
- The time lived after the chosen starting point. The pipeline asks for this time to be greater with treatment than in a comparison under comparable starting conditions, without supplying a measured increase.
- Insulin signaling
- The cellular response to the hormone insulin, a bodily chemical messenger. S5 concerns reducing this response in particular tissues, rather than identifying a complete set of indispensable targets.
- Caloric restriction
- An intervention that reduces dietary energy intake. The supplied S4 record reports its survival benefit but does not specify the restriction amount or schedule.
- Nuclear factor erythroid 2-related factor 2 (Nrf2)
- The named biological factor removed in S4. Its detailed molecular function is not established by the supplied material; the relevant finding is that the tested intervention still extended life without it.
- C57BL6/J mice
- The named laboratory mouse strain studied in S4. The supplied finding concerns males of this strain and does not establish the same result in all mice or humans.
- Brain-derived neurotrophic factor and 7,8-dihydroxyflavone
- Brain-derived neurotrophic factor is the biological signal that S2 describes 7,8-dihydroxyflavone as mimicking. The supplied passage reports an effect of this compound on developing fat cells, not an established survival benefit.
- Precursor cells and cell development
- Precursor cells are cells that can develop into a more specialized cell type. S2 concerns a laboratory cell population capable of becoming fat cells and reports reduced progression toward that state.
- Mitochondrial biogenesis
- The process of making and expanding the cell's mitochondria, structures involved in supplying usable energy. S6 states that drugs can manipulate this process but does not establish that doing so extends life.
- Gene activity and expression
- These terms concern cells using information in genes to produce biological products. S7 compares activity patterns associated with longevity; an association does not establish that changing the pattern causes longer life.
- Signaling pathway
- A connected sequence of events through which cells respond to a signal. S8 discusses pathways implicated both in life-extending interventions and in muscle growth and adaptation.
- Skeletal muscle
- The muscle tissue involved in moving the skeleton. S8 raises the question of how interventions associated with longer life relate to this tissue's growth and adaptation.
- Every target in a defined set is indispensable If a treatment extends life and removing each target's contribution separately abolishes that benefit, each target is necessary under those tested conditions. A treatment intended to reproduce that result would depend on preserving those contributions, although necessity alone would not show that acting on the targets is sufficient.
- Only some proposed targets are indispensable If removing certain targets abolishes the benefit while removing others leaves it intact, the proposed set includes contributions that are not individually required. Reproducing every associated cellular change would then overstate what the survival evidence establishes as necessary.
- No individual target is indispensable If the treatment still extends life after each target is removed separately, the proposed individual targets fail the question's necessity criterion. That result would leave unresolved whether contributions can substitute for one another or whether the relevant targets lie elsewhere.
- The treatment does not extend life If copying the selected processes does not increase remaining life under comparable conditions, there is no demonstrated survival benefit for target removal to explain. The treatment could still change cells or tissues, but those changes would not establish the requested life extension.
Changing a process in a cell does not by itself establish that the change makes an organism live longer. A treatment could produce that cellular change while its effect on survival depends on another tissue, or while survival remains unchanged. Even when changing one tissue extends life, that does not establish that the tissue is indispensable to a different treatment's benefit. Confusing these steps would turn evidence of a cellular effect into an unsupported claim about a life-extending treatment and its required targets.
S-узлы описывают отдельные клеточные зависимости преимущественно уровня RL-1; состав достаточных наборов миметиков и мишеней отсутствует.
Определённый состав миметиков и необходимых мишеней, обеспечивающих отношение оставшейся продолжительности жизни выше единицы при сопоставимых исходных условиях.
Неизвестно, какие сочетания мишеней превращают воспроизведение отдельных физиологических звеньев в продление жизни и какие вещества способны воспроизвести это сочетание.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Минимальный набор мишеней миметика кишечного восстановления состоит из одной популяции: зрелых всасывающих эпителиальных клеток по краям микроповреждений. Гипотеза утверждает, что краткое усиление их эндоредупликации, то есть удвоения генома с увеличением клетки, воспроизводит физиологическую компенсацию утраченной поверхности и способно продлевать оставшуюся жизнь старых мышей. Возможное воздействие для проверки: адресная кратковременная экспрессия циклина E1 при обратимом ограничении митотического перехода исключительно в зрелых клетках. Предлагаемый объём воздействия определяется площадью дефекта: суммарная дополнительная апикальная площадь обработанных клеток должна как минимум равняться площади утраченного эпителия. Это геометрическая нижняя граница, а достаточность такого покрытия для восстановления функции составляет часть гипотезы. Меньший охват оставляет незакрытую поверхность. Обычное обновление кишечника сохраняется; дополнительное усиление стволового деления, иммунной защиты и перестройки матрикса для эффекта миметика считается избыточным. Предполагаемая цепочка: компенсация поверхности, сокращение длительности микродефектов, уменьшение повторного повреждения и увеличение SPV_2.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При сохранённом базовом обновлении эпителия миметик увеличивает оставшуюся продолжительность жизни даже тогда, когда дополнительное деление стволовых клеток удерживается на исходном уровне. Увеличенные зрелые клетки сохраняют свою идентичность и закрывают дефекты; образования новых стволовых клеток из них не происходит. Избирательное выключение эндоредупликации в зрелой популяции устраняет пользу, а её восстановление возвращает эффект. Если для выигрыша обязательно усиленное образование новых клеток, преимущество получают наборы 02 или 04.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable lifespan, cell identity and repair outcomes, plus loss and restoration of benefit upon disabling and restoring endoreduplication. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Происхождение клеток, плоидность, площадь их апикальной поверхности и число делений можно измерить в органоидах и мышиной кишке. Избирательное управление клеточным циклом остаётся экспериментальным инструментом. Главные ограничения: геномная нестабильность, нарушение всасывания и сохранение повреждённых клеток после увеличения.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При сохранённом базовом обновлении эпителия миметик увеличивает оставшуюся продолжительность жизни даже тогда, когда дополнительное деление стволовых клеток удерживается на исходном уровне. Увеличенные зрелые клетки сохраняют свою идентичность и закрывают дефекты; образования новых стволовых клеток из них не происходит. Избирательное выключение эндоредупликации в зрелой популяции устраняет пользу, а её восстановление возвращает эффект. Если для выигрыша обязательно усиленное образование новых клеток, преимущество получают наборы 02 или 04.
- Rival 01 of 03What would separate them
Reserve cells may extend life by restoring intestinal crypts after renewal cells are lost predicts: При одинаковом среднем числе новых эпителиальных клеток продление жизни возникает только при сохранённой способности Dll1-положительных предшественников восстанавливать крипты. Отключение этой способности увеличивает частоту редких необратимых потерь крипт и устраняет выигрыш выживаемости, хотя средний пролиферативный ответ остаётся прежним. Вероятность восстановления меняется с числом доступных резервных клеток по предсказанию модели. Сохранение пользы при выключенном резерве поддержит иной минимальный набор.
- Rival 02 of 03What would separate them
Mimicking gut glial signals may extend life through lymphoid and epithelial protection predicts: Миметик продлевает жизнь при сохранённой паре «RET-положительная лимфоидная клетка, эпителий с ответом на интерлейкин-22», даже если дополнительное привлечение секреторных предшественников и перестройка матрикса удерживаются на исходном уровне. Выключение RET исключительно в этих лимфоидных клетках или рецепторного ответа на интерлейкин-22 в эпителии устраняет пользу. Прямое введение интерлейкина-22 должно обходить первое выключение, но не второе. Если прямой эпителиальный миметик даёт тот же долговременный эффект, двухпопуляционный набор оказывается больше необходимого для этого альтернативного препарата.
- Rival 03 of 03What would separate them
Restoring support flexibility may let intestinal progenitors complete repair and extend life predicts: Выигрыш оставшейся продолжительности жизни сопровождается восстановлением механических свойств перикриптальной опоры и исчезает, если матрикс экспериментально удерживается в исходном жёстком состоянии при сохранённом химическом воздействии. Обходное восстановление податливости опоры возвращает пользу. Избирательное выключение дополнительного механического ответа эпителиальных предшественников также устраняет эффект. При этой гипотезе усиление лимфоидной секреции или доступности резервных предшественников само по себе оставляет хронические дефекты при прежней механике матрикса.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
После повреждения кишечника дрозофилы усиленное увеличение клеток и их плоидности участвует в восстановлении эпителия. Работа подтверждает роль постмитотического роста, но сохраняет участие стволовых клеток: [EGFR-dependent TOR-independent endocycles support Drosophila gut epithelial regeneration](https://pmc.ncbi.nlm.nih.gov/articles/PMC5436070/).
Геронтология кишечника, учебный раздел «Стволовое обновление эпителия и возрастная регенеративная недостаточность». Пересмотра потребует утверждение, что дополнительная регенерация клетками-предшественниками необходима для долговременной пользы миметика восстановления.
Продление жизни старых мышей за счёт увеличения зрелых кишечных клеток при неизменном дополнительном выходе клеток из крипт и отсутствии усиления опухолевого роста.
Прямое обоснование достаточности одного зрелого клеточного компартмента для продления жизни старого млекопитающего в проверенных источниках не найдено. Однако ограниченный поиск не доказывает отсутствия такой идеи во всей литературе; строгий тест исключительной новизны остаётся незавершённым.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.